Temporal changes in liver stiffness after Fontan operation: Results of serial magnetic resonance elastography

被引:40
作者
Egbe, Alexander [1 ]
Miranda, William R. [1 ]
Connolly, Heidi M. [1 ]
Khan, Arooj R. [1 ]
Al-Otaibi, Mohamad [1 ]
Venkatesh, Sudhakar K. [2 ]
Simonetto, Douglas [3 ]
Kamath, Patrick [3 ]
Warnes, Carole [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55906 USA
[2] Mayo Clin, Dept Radiol, Rochester, MN 55906 USA
[3] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55906 USA
关键词
Fontan associated liver disease; Cirrhosis; Liver stiffness; Magnetic resonance elastography; HEPATIC-FIBROSIS; DISEASE; CIRCULATION; PHYSIOLOGY; MELD;
D O I
10.1016/j.ijcard.2018.01.108
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship between temporal progression of magnetic resonance elastography derived liver stiffness (MRE-LS) and progression of Fontan associated liver disease (FALD) is unknown. To assess this relationship, we hypothesized that progression of MRE-LS correlated with progression FALD severity and clinical outcomes. Methods: Retrospective review of Fontan patients who had > 1 liver MRE, 2010-2016. Annual change in MRE-LS was the quotient of the difference between baseline and subsequent MRE-LS, and the interval between scans. Results: 22 patients were enrolled; median age 29(19-38) years, 14 (64%) males and 10 (46%) with atiiopulmonary Fontan. Baseline and subsequent MRE-LS values were 5.4 +/- 1.1 kPa and 5.8 +/- 0.9 kPa" for clarity, interval between scans was 25 5 months, and annual change in MRE-LS was 0.3 +/- 02 kPa. Temporal change in MRE-LS correlated with temporal changes in model for end-stage liver disease (MELD) score (r = 0.84, p < 0.001) and model for end-stage liver disease excluding international normalized ratio (MELD-XI) score (r = 0.75, p = 0.001). The study cohort was divided into 2 groups using the mean annual change in MRE-LS as the cut point. Groups A and B comprised of patients with annual increase in MRE-LS >= 0.3 kPa (n = 6) and < 0.3 kPa (n = 16) respectively. Composite adverse event endpoint (death, heart-liver transplant listing, palliative care, hospitalization, paracentesis) was more common in Group A (4 of 6, 67%) compared to Group B (3 of 16, 19%), p = 0.13 although this did not reach statistical significance clue to small sample size. Conclusions: Progression of MRE-LS correlated with clinical deterioration as measured by worsening liver disease severity scores and the occurrence of adverse events. (C) 2017 Elsevier B.V. All rights reserved,
引用
收藏
页码:299 / 304
页数:6
相关论文
共 19 条
[1]   Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy? [J].
Agnoletti, Gabriella ;
Ferraro, Gaetana ;
Bordese, Roberto ;
Marini, Davide ;
Gala, Simona ;
Bergamasco, Laura ;
Ferroni, Francesca ;
Calvo, Pier Luigi ;
Barletti, Claudio ;
Cisaro, Fabio ;
Longo, Filomena ;
Napoleone, Carlo Pace .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 :60-65
[2]   MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery [J].
Assenza, Gabriele Egidy ;
Graham, Dionne A. ;
Landzberg, Michael J. ;
Valente, Anne Marie ;
Singh, Michael N. ;
Bashir, Aamir ;
Fernandes, Susan ;
Mortele, Koenraad J. ;
Ukomadu, Chinweike ;
Volpe, Massimo ;
Wu, Fred .
HEART, 2013, 99 (07) :491-496
[3]   Fontan-associated liver disease: Spectrum of US findings [J].
Bae, Jung Min ;
Jeon, Tae Yeon ;
Kim, Jung Sun ;
Kim, Seokhwi ;
Hwang, Sook Min ;
Yoo, Young ;
Kim, Ji Hye .
EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (04) :850-856
[4]   Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study [J].
Elder, Robert W. ;
McCabe, Nancy M. ;
Hebson, Camden ;
Veledar, Emir ;
Romero, Rene ;
Ford, Ryan M. ;
Mahle, William T. ;
Kogon, Brian E. ;
Sahu, Anurag ;
Jokhadar, Maan ;
McConnell, Michael E. ;
Book, Wendy M. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) :3764-3769
[5]   The Fontan circulation after 45 years: update in physiology [J].
Gewillig, Marc ;
Brown, Stephen C. .
HEART, 2016, 102 (14) :1081-1086
[6]  
Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9
[7]   The Model for End-stage Liver Disease (MELD) [J].
Kamath, Patrick S. ;
Kim, W. Ray .
HEPATOLOGY, 2007, 45 (03) :797-805
[8]   Impact of Liver Disease After the Fontan Operation [J].
Lindsay, Ian ;
Johnson, Joy ;
Everitt, Melanie D. ;
Hoffman, James ;
Yetman, Anji T. .
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (02) :249-252
[9]   Abdominal Imaging Surveillance in Adult Patients After Fontan Procedure: Risk of Chronic Liver Disease and Hepatocellular Carcinoma [J].
Nandwana, Sadhna B. ;
Olaiya, Babatunde ;
Cox, Kelly ;
Sahu, Anurag ;
Mittal, Pardeep .
CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2018, 47 (01) :19-22
[10]   Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation [J].
Poterucha, Joseph T. ;
Johnson, Jonathan N. ;
Qureshi, M. Yasir ;
O'Leary, Patrick W. ;
Kamath, Patrick S. ;
Lennon, Ryan J. ;
Bonnichsen, Crystal R. ;
Young, Phillip M. ;
Venkatesh, Sudhakar K. ;
Ehman, Richard L. ;
Gupta, Sounak ;
Smyrk, Thomas C. ;
Dearani, Joseph A. ;
Warnes, Carole A. ;
Cetta, Frank .
MAYO CLINIC PROCEEDINGS, 2015, 90 (07) :882-894